Early approval of Alnylam's gene-silencing drug in question

Alnylam Pharmaceuticals Inc said early data from its trial for gene-silencing drug givosiran showed it was effective, but indicated that there might be a delay in seeking accelerated approval.

from Reuters: Health News https://ift.tt/2xTjUni